We are live on
!
Find out more
TOCUITCONY
Trustees of Columbia University in the City of New York Portfolio holdings
AUM
$891M
1-Year Est. Return
17.3%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+17.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$48.5M
AUM Growth
–
Cap. Flow
+$50.7M
Cap. Flow
% of AUM
104.42%
Top 10 Holdings %
Top 10 Hldgs %
97.65%
Holding
15
New
15
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$34.1M |
| 2 |
Disc Medicine
IRON
|
+$5.5M |
| 3 |
VIGL
Vigil Neuroscience
VIGL
|
+$2.37M |
| 4 |
TransDigm Group
TDG
|
+$1.83M |
| 5 |
CFLT
Confluent
CFLT
|
+$1.51M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 74.12% |
| 2 | Healthcare | 18.39% |
| 3 | Industrials | 4.03% |
| 4 | Technology | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class A
BRK.A
$1.08T
| $35.6M | 73.42% |
+76
| New | +$34.1M |
|
|
VIGL
2
DELISTED
Vigil Neuroscience
VIGL
| $2.41M | 4.97% |
+192,973
| New | +$2.37M |
|
|
3
Disc Medicine
IRON
$3.06B
| $2.2M | 4.53% |
+110,488
| New | +$5.5M |
|
|
4
TransDigm Group
TDG
$68B
| $1.95M | 4.03% |
+3,103
| New | +$1.83M |
|
|
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
| $1.45M | 2.99% |
+9,173
| New | +$1.47M |
|
|
CFLT
6
DELISTED
Confluent
CFLT
| $1.45M | 2.99% |
+65,191
| New | +$1.51M |
|
7
Xilio Therapeutics
XLO
$59.8M
| $672K | 1.39% |
+17,831
| New | +$602K |
|
8
Vor Biopharma
VOR
$1.36B
| $611K | 1.26% |
+4,596
| New | +$455K |
|
9
Tenaya Therapeutics
TNYA
$168M
| $587K | 1.21% |
+291,828
| New | +$712K |
|
10
Surrozen
SRZN
$283M
| $419K | 0.86% |
+47,930
| New | +$1.01M |
|
|
JBIO
11
Jade Biosciences
JBIO
$1.47B
| $386K | 0.8% |
+377
| New | +$274K |
|
|
12
Berkshire Hathaway Class B
BRK.B
$1.09T
| $340K | 0.7% |
+1,100
| New | +$327K |
|
13
Amplitude
AMPL
$1.56B
| $229K | 0.47% |
+18,944
| New | +$268K |
|
|
EVLO
14
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $183K | 0.38% |
+5,693
| New | +$225K |
|
|
SRZNW
15
DELISTED
Surrozen Inc Warrant
SRZNW
| $3K | 0.01% |
+33,333
| New | +$4.98K |
|
Similar funds
SFM
BFFIM
FCM
SI
FTM
WIC
I
GEM
Trustees of Columbia University in the City of New York's Q4 2022 Portfolio in Review
As of Q4 2022, Trustees of Columbia University in the City of New York held 15 positions worth $48.5M. Its ten largest holdings account for 98% of the portfolio.
Trustees of Columbia University in the City of New York deployed $50.7M of net new capital in Q4 2022, opening 15 new positions. Its largest new stake was Berkshire Hathaway Class A: 76 shares worth $35.6M.
By sector, the portfolio is most concentrated in Financials at 74% of assets, followed by Healthcare and Industrials.
- Trustees of Columbia University in the City of New York's largest Q4 2022 buy was Berkshire Hathaway Class A: 76 shares worth $35.6M.
- Trustees of Columbia University in the City of New York's ten largest holdings make up 98% of its $48.5M portfolio in Q4 2022.
- Trustees of Columbia University in the City of New York opened 15 new positions and closed 0 in Q4 2022.
Based on Trustees of Columbia University in the City of New York's 13F filing for Q4 2022, filed 15 Feb 2023.